BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 33994184)

  • 1. Clinical Significance of Isolated V1 Arteritis in Renal Transplantation.
    Mikhail D; Chan E; Sharma H; Kleinsteuber D; Wei J; Rim C; Henein M; Sener A; Jevnikar AM; Gabril M; Moussa M; Luke PP
    Transplant Proc; 2021 Jun; 53(5):1570-1575. PubMed ID: 33994184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Designation of T-cell-mediated rejection type Ib and IIa reflects the type of rejection rather than the severity in the Banff classification.
    Wu K; Budde K; Schmidt D; Neumayer HH; Rudolph B
    Exp Clin Transplant; 2014 Oct; 12(5):415-23. PubMed ID: 25299369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Relationship of the Severity and Category of Acute Rejection With Intimal Arteritis Defined in Banff Classification to Clinical Outcomes.
    Wu K; Budde K; Schmidt D; Neumayer HH; Rudolph B
    Transplantation; 2015 Aug; 99(8):e105-14. PubMed ID: 25719260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reassessing the Significance of Intimal Arteritis in Kidney Transplant Biopsy Specimens.
    Salazar ID; Merino López M; Chang J; Halloran PF
    J Am Soc Nephrol; 2015 Dec; 26(12):3190-8. PubMed ID: 25918035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and Pathological Analyses of Cases of Acute Vascular Rejection After Kidney Transplantation.
    Shimizu T; Ishida H; Hayakawa N; Shibahara R; Tanabe K
    Transplant Proc; 2017 Dec; 49(10):2251-2255. PubMed ID: 29198655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The severity of acute cellular rejection defined by Banff classification is associated with kidney allograft outcomes.
    Wu K; Budde K; Lu H; Schmidt D; Liefeldt L; Glander P; Neumayer HH; Rudolph B
    Transplantation; 2014 Jun; 97(11):1146-54. PubMed ID: 24892962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term kidney allograft survival in patients with transplant glomerulitis.
    Nabokow A; Dobronravov VA; Khrabrova M; Gröne HJ; Gröne E; Hallensleben M; Kieneke D; Weithofer P; Smirnov AV; Kliem V
    Transplantation; 2015 Feb; 99(2):331-9. PubMed ID: 25594551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolated v-lesion in kidney transplant recipients: Characteristics, association with DSA, and histological follow-up.
    Rabant M; Boullenger F; Gnemmi V; Pellé G; Glowacki F; Hertig A; Brocheriou I; Suberbielle C; Taupin JL; Anglicheau D; Legendre C; Duong Van Huyen JP; Buob D
    Am J Transplant; 2018 Apr; 18(4):972-981. PubMed ID: 29206350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathologic analysis of acute vascular rejection cases after renal transplantation.
    Shimizu T; Tanabe T; Omoto K; Ishida H; Tanabe K
    Transplant Proc; 2012 Jan; 44(1):230-5. PubMed ID: 22310621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bowman capsulitis predicts poor kidney allograft outcome in T cell-mediated rejection.
    Gallan AJ; Chon WJ; Josephson MA; Cunningham PN; Henriksen KJ; Chang A
    Hum Pathol; 2018 Jun; 76():47-51. PubMed ID: 29501487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute vascular rejection after renal transplantation and isolated v-lesion.
    Shimizu T; Tanabe T; Shirakawa H; Omoto K; Ishida H; Tanabe K
    Clin Transplant; 2012 Jul; 26 Suppl 24():2-8. PubMed ID: 22747468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute cellular rejection: impact of donor-specific antibodies and C4d.
    Willicombe M; Roufosse C; Brookes P; McLean AG; Galliford J; Cairns T; Cook TH; Taube D
    Transplantation; 2014 Feb; 97(4):433-9. PubMed ID: 24430742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of renal transplant histology at three months.
    Kuypers DR; Chapman JR; O'Connell PJ; Allen RD; Nankivell BJ
    Transplantation; 1999 May; 67(9):1222-30. PubMed ID: 10342313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cell-mediated rejection is a major determinant of inflammation in scarred areas in kidney allografts.
    Lefaucheur C; Gosset C; Rabant M; Viglietti D; Verine J; Aubert O; Louis K; Glotz D; Legendre C; Duong Van Huyen JP; Loupy A
    Am J Transplant; 2018 Feb; 18(2):377-390. PubMed ID: 29086461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical and pathological significance of borderline T cell-mediated rejection.
    Nankivell BJ; Agrawal N; Sharma A; Taverniti A; P'Ng CH; Shingde M; Wong G; Chapman JR
    Am J Transplant; 2019 May; 19(5):1452-1463. PubMed ID: 30501008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute Antibody-Mediated Rejection in Kidney Transplant Based on the 2013 Banff Criteria: Single-Center Experience in Uruguay.
    Nin M; Coitiño R; Kurdian M; Orihuela L; Astesiano R; Garau M; López D; Rievas G; Rodriguez I; González-Martínez F; Noboa O
    Transplant Proc; 2016 Mar; 48(2):612-5. PubMed ID: 27110014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of isolated v lesions in paediatric renal transplant biopsies: muscular arteries required to refute the diagnosis of acute rejection.
    Brown CC; Sebire NJ; Wittenhagen P; Shaw O; Marks SD
    Transpl Int; 2014 Feb; 27(2):170-5. PubMed ID: 24329984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute renal allograft rejection with severe tubulitis (Banff 1997 grade IB).
    Minervini MI; Torbenson M; Scantlebury V; Vivas C; Jordan M; Shapiro R; Randhawa PS
    Am J Surg Pathol; 2000 Apr; 24(4):553-8. PubMed ID: 10757402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of revised criteria for chronic active T cell-mediated rejection in the 2017 Banff classification: Surveillance by 1-year protocol biopsies for kidney transplantation.
    Nakagawa K; Tsuchimoto A; Ueki K; Matsukuma Y; Okabe Y; Masutani K; Unagami K; Kakuta Y; Okumi M; Nakamura M; Nakano T; Tanabe K; Kitazono T;
    Am J Transplant; 2021 Jan; 21(1):174-185. PubMed ID: 32484280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-transplant donor specific antibody is associated with poor kidney transplant outcomes only when combined with both T-cell-mediated rejection and non-adherence.
    Cherukuri A; Mehta R; Sharma A; Sood P; Zeevi A; Tevar AD; Rothstein DM; Hariharan S
    Kidney Int; 2019 Jul; 96(1):202-213. PubMed ID: 31029504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.